BRCA1 and neoplasm: Furthermore, there was no evidence of variation in the distributions of ER or PR status across the studies separately for BRCA1 and BRCA2 tumours (Mavaddat N, Antoniou AC, personal communication, manuscript in preparation) and all analyses were stratified by country.